Kodak Reports Second-Quarter 2024 Financial Results
Eastman Kodak Company (NYSE: KODK) reported its Q2 2024 financial results, showing mixed performance. Consolidated revenues decreased by 9% to $267 million, while gross profit fell 8% to $58 million. However, the gross profit percentage increased by 1 percentage point to 22%. GAAP net income declined 26% to $26 million, and Operational EBITDA decreased 45% to $12 million. The company's cash balance stood at $251 million, down $4 million from December 31, 2023.
Despite revenue decline, Kodak achieved a year-over-year increase in gross profit percentage for the seventh consecutive quarter. The company continues to invest in its Advanced Materials & Chemicals group and is seeing revenue growth in key product areas. Kodak's cGMP facility for manufacturing diagnostic test reagents is scheduled to begin production in 2025.
Eastman Kodak Company (NYSE: KODK) ha riportato i risultati finanziari del secondo trimestre 2024, mostrando una performance mista. I ricavi consolidati sono diminuiti del 9% a $267 milioni, mentre il profitto lordo è sceso dell'8% a $58 milioni. Tuttavia, la percentuale di profitto lordo è aumentata di 1 punto percentuale al 22%. Il reddito netto GAAP è calato del 26% a $26 milioni e l'EBITDA operativo è sceso del 45% a $12 milioni. Il saldo di cassa dell'azienda era di $251 milioni, in diminuzione di $4 milioni rispetto al 31 dicembre 2023.
Nonostante il calo dei ricavi, Kodak ha registrato un aumento anno dopo anno nella percentuale di profitto lordo per il settimo trimestre consecutivo. L'azienda continua a investire nel suo gruppo di Materiali Avanzati e Chimica, osservando una crescita dei ricavi in aree di prodotto chiave. L'impianto cGMP di Kodak per la produzione di reagenti per test diagnostici è previsto per iniziare la produzione nel 2025.
Eastman Kodak Company (NYSE: KODK) informó sobre sus resultados financieros del segundo trimestre de 2024, mostrando un desempeño mixto. Los ingresos consolidados disminuyeron un 9% a $267 millones, mientras que el beneficio bruto cayó un 8% a $58 millones. Sin embargo, el porcentaje de beneficio bruto aumentó en 1 punto porcentual al 22%. El ingreso neto GAAP disminuyó un 26% a $26 millones y el EBITDA operativo cayó un 45% a $12 millones. El saldo de efectivo de la compañía se situó en $251 millones, una disminución de $4 millones desde el 31 de diciembre de 2023.
A pesar de la disminución de ingresos, Kodak logró un aumento interanual en el porcentaje de beneficio bruto durante el séptimo trimestre consecutivo. La empresa sigue invirtiendo en su grupo de Materiales Avanzados y Químicos y está viendo un crecimiento de ingresos en áreas clave de productos. La instalación de cGMP de Kodak para la fabricación de reactivos de pruebas diagnósticas comenzará a producirse en 2025.
이스트맨 코닥 컴퍼니 (NYSE: KODK)는 2024년 2분기 재무 결과를 발표하며 혼합 성과를 보여주었습니다. 통합 매출은 9% 감소한 2억 6,700만 달러였고, 총 이익은 8% 감소한 5,800만 달러로 나타났습니다. 하지만 총 이익률은 1% 포인트 증가하여 22%에 달했습니다. GAAP 순이익은 26% 감소한 2,600만 달러였으며, 운영 EBITDA는 45% 감소한 1,200만 달러로 집계되었습니다. 회사의 현금잔고는 2억 5,100만 달러로, 2023년 12월 31일 기준으로 400만 달러 감소했습니다.
수익 감소에도 불구하고, 코닥은 7분기 연속으로 총 이익률의 연간 증가를 달성했습니다. 회사는 고급 재료 및 화학 그룹에 지속적으로 투자하고 있으며, 주요 제품 분야에서 매출 성장을 보고하고 있습니다. 코닥의 진단 테스트 시약 제조를 위한 cGMP 시설은 2025년에 생산을 시작할 예정입니다.
La société Eastman Kodak (NYSE: KODK) a publié ses résultats financiers pour le deuxième trimestre 2024, affichant des performances mitigées. Les revenus consolidés ont diminué de 9% pour atteindre 267 millions de dollars, tandis que le bénéfice brut a chuté de 8% à 58 millions de dollars. Cependant, le pourcentage de bénéfice brut a augmenté de 1 point de pourcentage pour atteindre 22%. Le revenu net GAAP a baissé de 26% à 26 millions de dollars, et l'EBITDA opérationnel a diminué de 45% pour s'établir à 12 millions de dollars. Le solde de trésorerie de l'entreprise s'élevait à 251 millions de dollars, en baisse de 4 millions de dollars par rapport au 31 décembre 2023.
Malgré la baisse des revenus, Kodak a enregistré une augmentation de projet brut d'année en année pour le septième trimestre consécutif. L'entreprise continue d'investir dans son groupe Matériaux et Chimie Avancée et constate une croissance des revenus dans des domaines de produits clés. L'installation cGMP de Kodak pour la fabrication de réactifs pour tests diagnostiques est prévue pour commencer la production en 2025.
Die Eastman Kodak Company (NYSE: KODK) hat ihre Finanzergebnisse für das zweite Quartal 2024 veröffentlicht, die gemischte Leistungen zeigen. Die konsolidierten Einnahmen sanken um 9% auf 267 Millionen US-Dollar, während der Bruttogewinn um 8% auf 58 Millionen US-Dollar fiel. Der Bruttogewinnanteil hingegen stieg um 1 Prozentpunkt auf 22%. Der GAAP-Nettoertrag ging um 26% auf 26 Millionen US-Dollar zurück, und das operative EBITDA sank um 45% auf 12 Millionen US-Dollar. Der Bargeldbestand des Unternehmens betrug 251 Millionen US-Dollar, was einem Rückgang von 4 Millionen US-Dollar seit dem 31. Dezember 2023 entspricht.
Trotz des Rückgangs der Einnahmen erzielte Kodak im Vergleich zum Vorjahr eine Steigerung des Bruttogewinnanteils im siebten Quartal in Folge. Das Unternehmen investiert weiterhin in seine Gruppe für fortschrittliche Materialien und Chemikalien und verzeichnet ein Umsatzwachstum in wichtigen Produktbereichen. Das cGMP-Werk von Kodak zur Herstellung von Reagenzien für diagnostische Tests soll 2025 mit der Produktion beginnen.
- Gross profit percentage increased to 22%, up 1 percentage point year-over-year
- Seventh consecutive quarter of year-over-year increase in gross profit percentage
- Growing revenue in key product areas within Advanced Materials & Chemicals group
- New cGMP facility for diagnostic test reagents on track to begin production in 2025
- Commitments secured for several KODAK PROSPER ULTRA 520 Presses
- Consolidated revenues decreased 9% year-over-year to $267 million
- GAAP net income declined 26% to $26 million
- Operational EBITDA decreased 45% to $12 million
- Cash balance reduced by $4 million to $251 million since December 31, 2023
- Lower volumes and higher manufacturing costs impacted financial performance
Insights
Kodak's Q2 2024 results paint a mixed picture. While revenues declined
However, the decline in GAAP net income by
Kodak's focus on its Advanced Materials & Chemicals group and the upcoming cGMP facility for diagnostic test reagents could provide future growth opportunities. However, the company needs to demonstrate that its investments and efficiency initiatives will translate into improved financial performance in the coming quarters.
Kodak's performance in Q2 2024 reflects broader industry trends and challenges. The
The slight growth in the Advanced Materials & Chemicals segment is promising, indicating potential diversification opportunities. The upcoming cGMP facility for diagnostic test reagents production could position Kodak in the growing healthcare and life sciences markets.
Kodak's strategy of prioritizing "smart revenue" over volume is a calculated risk. While it's improving gross profit percentages, the company must ensure this approach doesn't lead to a continued decline in overall revenue and profitability. The success of this strategy will likely depend on Kodak's ability to innovate and capture high-value market segments in both its traditional and new business areas.
ROCHESTER, N.Y., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Eastman Kodak Company (NYSE: KODK) today reported financial results for the second quarter 2024.
Second-quarter 2024 highlights include:
- Consolidated revenues of
$267 million , compared with$295 million for Q2 2023, a decrease of$28 million or 9 percent - Gross profit of
$58 million , compared with$63 million for Q2 2023, a decrease of$5 million or 8 percent - Gross profit percentage of 22 percent, compared with 21 percent for Q2 2023, an increase of 1 percentage point
- GAAP net income of
$26 million , compared with net income of$35 million for Q2 2023, a decrease of$9 million or 26 percent - Operational EBITDA of
$12 million , compared with$22 million for Q2 2023, a decrease of$10 million or 45 percent - A quarter-end cash balance of
$251 million , compared with$255 million on December 31, 2023, a decrease of$4 million
“Our results for the second quarter were in line with our long-term strategic plan: we delivered a year-over-year increase in gross profit percentage for the seventh consecutive quarter despite an anticipated decline in revenue. We are getting leaner, introducing new products and partnering with the right customers,” said Jim Continenza, Kodak’s Executive Chairman and CEO. “Building for the future, we continue to invest in our Advanced Materials & Chemicals group and are seeing results in terms of growing revenue in key product areas. The cGMP facility for manufacturing diagnostic test reagents under construction at Eastman Business Park is scheduled to begin production in 2025. In our commercial print business, our participation in the drupa tradeshow earlier this year demonstrated our ability to provide leading-edge solutions for both offset and digital print. We are starting to gain momentum with our groundbreaking continuous inkjet press portfolio, announcing commitments for several KODAK PROSPER ULTRA 520 Presses from the show. Looking forward, we will continue to execute the long-term plan which has created a foundation for growth: increasing efficiency, investing in innovation and infrastructure and focusing on generating smart revenue.”
For the quarter ended June 30, 2024, revenues were
GAAP net income was
Kodak ended the quarter with a cash balance of
“Kodak continued to see an improvement in gross profit margins year-over-year for the quarter, reaching 22 percent in Q2,” said David Bullwinkle, Kodak’s CFO. “The decline in revenue was driven by our focus on generating smart revenue to strengthen the profitability of our businesses. Our quarter-end cash balance of
##
Revenue and Operational EBITDA by Reportable Segment Q2 2024 vs. Q2 2023
| ($ millions) | ||||||||||||||||
| Q2 2024 Actuals | Advanced Materials & Chemicals | Brand | Total | |||||||||||||
| Revenue | $ | 186 | $ | 73 | $ | 4 | $ | 263 | ||||||||
| Operational EBITDA * | $ | - | $ | 8 | $ | 4 | $ | 12 | ||||||||
| Q2 2023 Actuals | Advanced Materials & Chemicals | Brand | Total | |||||||||||||
| Revenue | $ | 215 | $ | 72 | $ | 4 | $ | 291 | ||||||||
| Operational EBITDA * | $ | 8 | $ | 11 | $ | 3 | $ | 22 | ||||||||
| Q2 2024 vs. Q2 2023 Actuals B/(W) | Advanced Materials & Chemicals | Brand | Total | |||||||||||||
| Revenue | $ | (29 | ) | $ | 1 | $ | - | $ | (28 | ) | ||||||
| Operational EBITDA * | $ | (8 | ) | $ | (3 | ) | $ | 1 | $ | (10 | ) | |||||
| Q2 2024 Actuals on constant currency ** vs. Q2 2023 Actuals B/(W) | Advanced Materials & Chemicals | Brand | Total | |||||||||||||
| Revenue | $ | (25 | ) | $ | 1 | $ | - | $ | (24 | ) | ||||||
| Operational EBITDA * | $ | (8 | ) | $ | (3 | ) | $ | 1 | $ | (10 | ) | |||||
* Total Operational EBITDA is a non-GAAP financial measure. The reconciliation between GAAP and non-GAAP measures is provided in Appendix A of this press release.
** The impact of foreign exchange represents the foreign exchange impact using average foreign exchange rates for the three months ended June 30, 2023, rather than the actual average exchange rates in effect for the three months ended June 30, 2024.
Eastman Business Park segment is not a reportable segment and is excluded from the table above.
About Kodak
Kodak (NYSE: KODK) is a leading global manufacturer focused on commercial print and advanced materials & chemicals. With 79,000 worldwide patents earned over 130 years of R&D, we believe in the power of technology and science to enhance what the world sees and creates. Our innovative, award-winning products, combined with our customer-first approach, make us the partner of choice for commercial printers worldwide. Kodak is committed to environmental stewardship, including industry leadership in developing sustainable solutions for print. For additional information on Kodak, visit us at kodak.com, or follow us on X @Kodak and LinkedIn.
Cautionary Statement Regarding Forward-Looking Statements
This press release includes “forward-looking statements” as that term is defined under the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning Kodak’s plans, objectives, goals, strategies, future events, future revenue or performance, capital expenditures, liquidity, investments, financing needs and business trends and other information that is not historical information. When used in this press release, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “predicts,” “forecasts,” “strategy,” “continues,” “goals,” “targets” or future or conditional verbs, such as “will,” “should,” “could,” or “may,” and similar words and expressions, as well as statements that do not relate strictly to historical or current facts, are intended to identify forward-looking statements. All forward-looking statements, including management’s examination of historical operating trends and data, are based upon Kodak’s current expectations and assumptions. Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from historical results or those expressed in or implied by such forward-looking statements.
Important factors that could cause actual events or results to differ materially from the forward-looking statements include, among others, the risks and uncertainties described in more detail in Kodak’s Annual Report on Form 10-K for the year ended December 31, 2023 under the headings “Business,” “Risk Factors,” “Legal Proceedings,” and/or “Management’s Discussion and Analysis of Financial Condition and Results of Operations–Liquidity and Capital Resources,” in the corresponding sections of Kodak’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2024 and June 30, 2024, and in other filings Kodak makes with the U.S. Securities and Exchange Commission from time to time, as well as the following: Kodak’s ability to improve and sustain its operating structure, cash flow, profitability and other financial results; Kodak’s ability to achieve strategic objectives, cash forecasts, financial projections, and projected growth; Kodak’s ability to achieve the financial and operational results contained in its business plans; Kodak’s ability to obtain additional or alternate financing if and as needed, Kodak’s continued ability to manage world-wide cash through inter-company loans, distributions and other mechanisms, and Kodak’s ability to provide or facilitate financing for its customers; Kodak’s ability to fund continued investments, capital needs and collateral requirements and service its debt and Series B Preferred Stock and Series C Preferred Stock; Changes in foreign currency exchange rates, commodity prices, interest rates and tariff rates; the impact of the global economic environment, including inflationary pressures, geopolitical issues such as the war in Ukraine and conflicts involving Israel, medical epidemics, and Kodak’s ability to effectively mitigate the associated increased costs of aluminum and other raw materials, energy, labor, shipping, delays in shipment and production times, and fluctuations in demand; Kodak’s ability to effectively compete with large, well-financed industry participants or with competitors whose cost structure is lower than Kodak’s; the performance by third parties of their obligations to supply products, components or services to Kodak and Kodak’s ability to address supply chain disruptions and continue to obtain raw materials and components available from single or limited sources of supply, which may be adversely affected by the war in Ukraine, the conflicts involving Israel, and residual effects of the COVID-19 pandemic; Kodak’s ability to comply with the covenants in its various credit facilities; Kodak’s ability to effectively anticipate technology and industry trends and develop and market new products, solutions and technologies, including products based on its technology and expertise that relate to industries in which it does not currently conduct material business; Kodak’s ability to effect strategic transactions, such as investments, acquisitions, strategic alliances, divestitures and similar transactions, or to achieve the benefits sought to be achieved from such strategic transactions; Kodak’s ability to discontinue, sell or spin-off certain non-core businesses or operations, or otherwise monetize assets; the impact of the investigations, litigation and claims arising out of the circumstances surrounding the announcement on July 28, 2020, by the U.S. International Development Finance Corporation of the signing of a non‐binding letter of interest to provide a subsidiary of Kodak with a potential loan to support the launch of an initiative for the manufacture of pharmaceutical ingredients for essential generic drugs; and the potential impact of force majeure events, cyber‐attacks or other data security incidents or information technology outages that could disrupt or otherwise harm Kodak’s operations.
Future events and other factors may cause Kodak’s actual results to differ materially from the forward-looking statements. All forward-looking statements attributable to Kodak or persons acting on its behalf apply only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included or referenced in this press release. Kodak undertakes no obligation to update or revise forward-looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events, except as required by law.
APPENDICES
In this second quarter 2024 financial results news release, reference is made to the following non-GAAP financial measures:
- Operational EBITDA; and
- Revenues on a constant currency basis.
Kodak believes that these non-GAAP measures represent important internal measures of performance. Accordingly, where they are provided, it is to give investors the same financial data management uses with the belief that this information will assist the investment community in properly assessing the underlying performance of Kodak, its financial condition, results of operations and cash flow.
Kodak’s segment measure of profit and loss is an adjusted earnings before interest, taxes, depreciation and amortization (“Operational EBITDA”). Operational EBITDA represents the earnings from operations excluding the provision for income taxes; non-service cost components of pension and other postemployment benefits income; depreciation and amortization expense; restructuring costs and other; stock-based compensation expense; consulting and other costs; idle costs; other operating expense (income); interest expense; and other expense, net.
The change in revenues on a constant currency basis, as presented in this financial results news release, is calculated by using average foreign exchange rates for the three months ended June 30, 2023, rather than the actual average exchange rates in effect for the three months ended June 30, 2024.
The following table reconciles the most directly comparable GAAP measure of Net Income to Operational EBITDA for the three months ended June 30, 2024 and 2023, respectively:
| (in millions) | ||||||||||||||
| Q2 2024 | Q2 2023 | $ Change | % Change | |||||||||||
| Net Income | $ | 26 | $ | 35 | $ | (9 | ) | -26 | % | |||||
| All other | - | (1 | ) | 1 | ||||||||||
| Depreciation and amortization | 6 | 8 | (2 | ) | ||||||||||
| Restructuring costs and other (3) | - | 5 | (5 | ) | ||||||||||
| Stock based compensation | 1 | 1 | - | |||||||||||
| Consulting and other costs (1) | 1 | (1 | ) | 2 | ||||||||||
| Idle costs (2) | 1 | 1 | - | |||||||||||
| Other operating expense (income), net (3) | 1 | (1 | ) | 2 | ||||||||||
| Interest expense (3) | 15 | 11 | 4 | |||||||||||
| Pension income excluding service cost component (3) | (41 | ) | (41 | ) | - | |||||||||
| Other expense, net (3) | 1 | 3 | (2 | ) | ||||||||||
| Provision for income taxes (3) | 1 | 2 | (1 | ) | ||||||||||
| Operational EBITDA | $ | 12 | $ | 22 | $ | (10 | ) | -45 | % | |||||
Footnote Explanations:
(1) Consulting and other costs are primarily professional services and internal costs associated with certain corporate strategic initiatives, investigations and litigation. Consulting and other costs included
(2) Consists of third-party costs such as security, maintenance, and utilities required to maintain land and buildings in certain locations not used in any Kodak operations and the costs, net of any rental income received, of underutilized portions of certain properties.
(3) As reported in the Consolidated Statement of Operations.
A. FINANCIAL STATEMENTS
| EASTMAN KODAK COMPANY | ||||||||
| CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) | ||||||||
| (in millions, except per share data) | Three Months Ended | |||||||
| June 30, | ||||||||
| 2024 | 2023 | |||||||
| Revenues | ||||||||
| Sales | $ | 227 | $ | 242 | ||||
| Services | 40 | 53 | ||||||
| Total revenues | 267 | 295 | ||||||
| Cost of revenues | ||||||||
| Sales | 181 | 195 | ||||||
| Services | 28 | 37 | ||||||
| Total cost of revenues | 209 | 232 | ||||||
| Gross profit | 58 | 63 | ||||||
| Selling, general and administrative expenses | 47 | 40 | ||||||
| Research and development costs | 8 | 9 | ||||||
| Restructuring costs and other | — | 5 | ||||||
| Other operating expense (income) net | 1 | (1 | ) | |||||
| Earnings rom operations before interest expense, pension income excluding service cost component, other expense, net and income taxes | 2 | 10 | ||||||
| Interest expense | 15 | 11 | ||||||
| Pension income excluding service cost component | (41 | ) | (41 | ) | ||||
| Other expense, net | 1 | 3 | ||||||
| Earnings from operations before income taxes | 27 | 37 | ||||||
| Provision for income taxes | 1 | 2 | ||||||
| NET EARNINGS | $ | 26 | $ | 35 | ||||
| Basic earnings per share attributable to Eastman Kodak Company common shareholders | $ | 0.25 | $ | 0.35 | ||||
| Diluted earnings per share attributable to Eastman Kodak Company common shareholders | $ | 0.23 | $ | 0.32 | ||||
The notes accompanying the financial statements contained in the Company’s second quarter 2024 Form 10-Q are an integral part of these consolidated financial statements.
| EASTMAN KODAK COMPANY | ||||||||
| CONSOLIDATED STATEMENT OF FINANCIAL POSITION (Unaudited) | ||||||||
| June 30, | December 31, | |||||||
| (in millions) | 2024 | 2023 | ||||||
| ASSETS | ||||||||
| Cash and cash equivalents | $ | 251 | $ | 255 | ||||
| Trade receivables, net of allowances of | 139 | 195 | ||||||
| Inventories, net | 232 | 217 | ||||||
| Other current assets | 38 | 45 | ||||||
| Total current assets | 660 | 712 | ||||||
| Property, plant and equipment, net of accumulated depreciation of | 177 | 169 | ||||||
| Goodwill | 12 | 12 | ||||||
| Intangible assets, net | 22 | 24 | ||||||
| Operating lease right-of-use assets | 29 | 30 | ||||||
| Restricted cash | 100 | 110 | ||||||
| Pension and other postretirement assets | 1,279 | 1,216 | ||||||
| Other long-term assets | 80 | 82 | ||||||
| TOTAL ASSETS | $ | 2,359 | $ | 2,355 | ||||
| LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND EQUITY | ||||||||
| Accounts payable, trade | $ | 128 | $ | 125 | ||||
| Short-term borrowings and current portion of long-term debt | 1 | 1 | ||||||
| Current portion of operating leases | 10 | 13 | ||||||
| Other current liabilities | 139 | 144 | ||||||
| Total current liabilities | 278 | 283 | ||||||
| Long-term debt, net of current portion | 453 | 457 | ||||||
| Pension and other postretirement liabilities | 224 | 237 | ||||||
| Operating leases, net of current portion | 25 | 24 | ||||||
| Other long-term liabilities | 204 | 213 | ||||||
| Total liabilities | 1,184 | 1,214 | ||||||
| Commitments and Contingencies (Note 6) | ||||||||
| Redeemable, convertible preferred stock, no par value, | 214 | 210 | ||||||
| Equity | ||||||||
| Common stock, | — | — | ||||||
| Additional paid in capital | 1,154 | 1,156 | ||||||
| Treasury stock, at cost | (12 | ) | (11 | ) | ||||
| Accumulated deficit | (437 | ) | (495 | ) | ||||
| Accumulated other comprehensive income | 256 | 281 | ||||||
| Total shareholders’ equity | 961 | 931 | ||||||
| TOTAL LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND EQUITY | $ | 2,359 | $ | 2,355 | ||||
The notes accompanying the financial statements contained in the Company’s second quarter 2024 Form 10-Q are an integral part of these consolidated financial statements.
| EASTMAN KODAK COMPANY | |||||||
| CONSOLIDATED STATEMENT OF CASH FLOW (Unaudited) | |||||||
| Six Months Ended | |||||||
| June 30, | |||||||
| (in millions) | 2024 | 2023 | |||||
| Cash flows from operating activities: | |||||||
| Net earnings | $ | 58 | $ | 68 | |||
| Adjustments to reconcile to net cash provided by operating activities: | |||||||
| Depreciation and amortization | 13 | 16 | |||||
| Pension and other postretirement income | (73 | ) | (72 | ) | |||
| Change in fair value of the Preferred Stock and Convertible Notes embedded derivatives | — | 2 | |||||
| Non-cash changes in workers' compensation and other employee benefit reserves | (1 | ) | — | ||||
| Stock based compensation | 4 | 5 | |||||
| Net gain on sale of assets | (17 | ) | (1 | ) | |||
| (Benefit) provision for deferred income taxes | (1 | ) | 1 | ||||
| Decrease in trade receivables | 51 | 17 | |||||
| (Increase) decrease in miscellaneous receivables | (1 | ) | 7 | ||||
| Increase in inventories | (18 | ) | (11 | ) | |||
| Decrease in trade payables | (1 | ) | (7 | ) | |||
| Decrease in liabilities excluding borrowings and trade payables | (22 | ) | (9 | ) | |||
| Other items, net | 18 | 5 | |||||
| Total adjustments | (48 | ) | (47 | ) | |||
| Net cash provided by operating activities | 10 | 21 | |||||
| Cash flows from investing activities: | |||||||
| Additions to properties | (19 | ) | (11 | ) | |||
| Proceeds from sale of assets | 17 | — | |||||
| Net cash used in investing activities | (2 | ) | (11 | ) | |||
| Cash flows from financing activities: | |||||||
| Repayment of Amended and Restated Term Loan Agreement | (17 | ) | — | ||||
| Preferred stock cash dividend payments | (2 | ) | (2 | ) | |||
| Treasury stock purchases | (1 | ) | — | ||||
| Net cash used in financing activities | (20 | ) | (2 | ) | |||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (5 | ) | (2 | ) | |||
| Net (decrease) increase in cash, cash equivalents and restricted cash | (17 | ) | 6 | ||||
| Cash, cash equivalents and restricted cash, beginning of period | 377 | 286 | |||||
| Cash, cash equivalents and restricted cash, end of period | $ | 360 | $ | 292 | |||
The notes accompanying the financial statements contained in the Company’s second quarter 2024 Form 10-Q are an integral part of these consolidated financial statements.
Media Contact:
Kurt Jaeckel, Kodak, +1 585-490-8646, kurt.jaeckel@kodak.com
Investor Contact:
Anthony Redding, Kodak, +1 585-724-4053, shareholderservices@kodak.com
FAQ
What was Kodak's revenue for Q2 2024?
How did Kodak's gross profit percentage change in Q2 2024?
What was Kodak's GAAP net income for Q2 2024?
How much cash did Kodak have at the end of Q2 2024?
When is Kodak's new cGMP facility expected to begin production?
